Vantage Hemp Co. has become a global leader in the production of CBD oil and isolates by meeting ICH Q7 and WHO GMP standards for the industry.
Vantage achieves EU and North American compliance, and internationally recognized pharmaceutical Good Manufacturing Practices (GMP) certifications.
Vantage Hemp Co. Submits a Drug Master File for CBD Distillate to the U.S. Food & Drug Administration
Vantage Hemp Co. further solidifies its position as an industry leader by its announcement of a DMF submission for its CBD distillate to the FDA.
Dive into the establishment of US hemp policy and the importance of selecting a pharmaceutically proficient CBD extractor and contract manufacturer.
As an active pharmaceutical ingredient (API) manufacturer, Vantage prepares for its DMF submissions to the FDA to support the quality and safety of its products.
Vantage is a global leader in the production of CBD extracts with its facilities achieving ICH Q7 and WHO Good Manufacturing Practices (GMP) certification.